Artesunate Regulates Neurite Outgrowth Inhibitor Protein B Receptor to Overcome Resistance to Sorafenib in Hepatocellular Carcinoma Cells

The multireceptor tyrosine kinase inhibitor sorafenib is a Food and Drug Administration-approved first-line drug for the treatment of advanced liver cancer that can reportedly extend overall survival in patients with advanced hepatocellular carcinoma (HCC). Primary and acquired resistance to sorafen...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wubin, Huang, Xiaoxu, Berges, Bradford K., Wang, Yue, An, Ni, Su, Rongjian, Lu, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946852/
https://www.ncbi.nlm.nih.gov/pubmed/33716742
http://dx.doi.org/10.3389/fphar.2021.615889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946852/
https://www.ncbi.nlm.nih.gov/pubmed/33716742
http://dx.doi.org/10.3389/fphar.2021.615889

Ejemplares similares